Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023)

Immuneering has reported Asset Utilization Ratio over the past 3 years, most recently at 0.0 for Q3 2023.

  • Quarterly results put Asset Utilization Ratio at 0.0 for Q3 2023, down 99.9% from a year ago — trailing twelve months through Sep 2023 was 0.0 (down 99.9% YoY), and the annual figure for FY2022 was 0.0, down 89.19%.
  • Asset Utilization Ratio for Q3 2023 was 0.0 at Immuneering, down from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IMRX hit a ceiling of 0.02 in Q3 2021 and a floor of 0.0 in Q3 2023.
  • Median Asset Utilization Ratio over the past 3 years was 0.0 (2022), compared with a mean of 0.01.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 80.32% in 2022 and later crashed 99.9% in 2023.
  • Immuneering's Asset Utilization Ratio stood at 0.01 in 2021, then crashed by 80.32% to 0.0 in 2022, then tumbled by 99.85% to 0.0 in 2023.
  • The last three reported values for Asset Utilization Ratio were 0.0 (Q3 2023), 0.0 (Q2 2023), and 0.0 (Q1 2023) per Business Quant data.